144 related articles for article (PubMed ID: 8055447)
21. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
[TBL] [Abstract][Full Text] [Related]
22. Case report and review of immunodeficiency-associated Burkitt lymphoma.
Johnson DH; Reske T; Ruiz M
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e121-5. PubMed ID: 25701328
[No Abstract] [Full Text] [Related]
23. Durable survival after chemotherapy in a HIV patient with Burkitt's lymphoma presenting with massive upper gastrointestinal bleeding.
Law MF; Chan HN; Pang CY; Lai HK; Ha CY; Ng C; Ho R; Wong CK; Yeung YM; Yip SF
Int J STD AIDS; 2016 Jul; 27(8):690-6. PubMed ID: 26185043
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
25. Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.
Geissler RG; Bergmann L; Hacker H; Knupp B; Walker B; Hoelzer D
Eur J Haematol; 1997 Apr; 58(4):286-8. PubMed ID: 9186541
[No Abstract] [Full Text] [Related]
26. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
[TBL] [Abstract][Full Text] [Related]
27. Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapy.
Gasparini M; Rottoli L; Massimino M; Gianni MC; Ballerini E; Ravagnani F; Pupa S; Fossati-Bellani F
Eur J Cancer; 1993; 29A(5):692-8. PubMed ID: 8471326
[TBL] [Abstract][Full Text] [Related]
28. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
29. Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
Mazza JJ; Hines JD; Andersen JW; Neiman RS; Mann R; Oken MM; O'Connell MJ
Leuk Lymphoma; 1995 Jul; 18(3-4):289-96. PubMed ID: 8535195
[TBL] [Abstract][Full Text] [Related]
30. Skin involvement in Burkitt's lymphoma.
Thakkar D; Lipi L; Misra R; Yadav SP
Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):251-252. PubMed ID: 29397332
[TBL] [Abstract][Full Text] [Related]
31. Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.
Thomas DA; Cortes J; O'Brien S; Pierce S; Faderl S; Albitar M; Hagemeister FB; Cabanillas FF; Murphy S; Keating MJ; Kantarjian H
J Clin Oncol; 1999 Aug; 17(8):2461-70. PubMed ID: 10561310
[TBL] [Abstract][Full Text] [Related]
32. [Acute kidney failure as the clinical presenting form of renal Burkitt's lymphoma in an HIV-positive patient].
Saurina A; Ramírez de Arellano M; Chiné M; Fulquet M; Lladó I; de las Cuevas X
Nefrologia; 2001; 21(6):601-5. PubMed ID: 11881432
[TBL] [Abstract][Full Text] [Related]
33. Liposomal cytarabine in cerebrospinal fluid.
Boyd K; Jenner M; Treleaven J; Kenny J; Rhoades E
Br J Haematol; 2009 Jun; 145(6):679. PubMed ID: 19076172
[No Abstract] [Full Text] [Related]
34. A case of primary hepatic Burkitt's lymphoma.
Lee SH; Kim HJ; Mun JS; Oh HC; Lee HW; Choi CH; Kim JW; Do JH; Kim JG; Chang SK; Kim MK
Korean J Gastroenterol; 2008 Apr; 51(4):259-64. PubMed ID: 18516006
[TBL] [Abstract][Full Text] [Related]
35. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
[TBL] [Abstract][Full Text] [Related]
36. Massive chemotherapy and autologous bone marrow transplantation in Burkitt's lymphoma: the first two patients successfully treated in Thailand.
Suvatte V; Issaragrisil S; Chandanayingyong D; Mahasandana C; Tanphaichitr VS; Jirapinyo P
J Med Assoc Thai; 1990 Oct; 73(10):572-80. PubMed ID: 2280205
[TBL] [Abstract][Full Text] [Related]
37. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma.
Hesseling PB; Molyneux E; Kamiza S; Broadhead R
Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):602-7. PubMed ID: 18417177
[TBL] [Abstract][Full Text] [Related]
38. Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.
Lacasce A; Howard O; Lib S; Fisher D; Weng A; Neuberg D; Shipp M
Leuk Lymphoma; 2004 Apr; 45(4):761-7. PubMed ID: 15160953
[TBL] [Abstract][Full Text] [Related]
39. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
[TBL] [Abstract][Full Text] [Related]
40. High-dose cyclophosphamide and intermediate-dose methotrexate for the treatment of far-advanced Burkitt's lymphoma.
Brecher ML; Gardner RV; Ettinger LJ; Tebbi CK; Green DM; Freeman AI
Am J Pediatr Hematol Oncol; 1985; 7(2):117-24. PubMed ID: 3842557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
